191 related articles for article (PubMed ID: 35937691)
1. Gut Microbiota Correlates With Clinical Responsiveness to Erythropoietin in Hemodialysis Patients With Anemia.
Zhu Y; Tang Y; He H; Hu P; Sun W; Jin M; Wang L; Xu X
Front Cell Infect Microbiol; 2022; 12():919352. PubMed ID: 35937691
[TBL] [Abstract][Full Text] [Related]
2. The prebiotic effects of soluble dietary fiber mixture on renal anemia and the gut microbiota in end-stage renal disease patients on maintenance hemodialysis: a prospective, randomized, placebo-controlled study.
Li Y; Han M; Song J; Liu S; Wang Y; Su X; Wei K; Xu Z; Li H; Wang Z
J Transl Med; 2022 Dec; 20(1):599. PubMed ID: 36517799
[TBL] [Abstract][Full Text] [Related]
3. Controlled study on the improvement of quality of life in elderly hemodialysis patients after correcting end-stage renal disease-related anemia with erythropoietin.
Moreno F; Aracil FJ; Pérez R; Valderrábano F
Am J Kidney Dis; 1996 Apr; 27(4):548-56. PubMed ID: 8678066
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic fatty liver disease (NAFLD)--is it a new marker of hyporesponsiveness to recombinant human erythropoietin in patients that are on chronic hemodialysis?
Orlic L; Mikolasevic I; Lukenda V; Racki S; Stimac D; Milic S
Med Hypotheses; 2014 Dec; 83(6):798-801. PubMed ID: 25456789
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Hemodialysis and Peritoneal Dialysis on the Gut Microbiota of End-Stage Renal Disease Patients, and the Relationship Between Gut Microbiota and Patient Prognoses.
Luo D; Zhao W; Lin Z; Wu J; Lin H; Li Y; Song J; Zhang J; Peng H
Front Cell Infect Microbiol; 2021; 11():579386. PubMed ID: 33834002
[TBL] [Abstract][Full Text] [Related]
6. Effect of intravenous ascorbic acid in hemodialysis patients with EPO-hyporesponsive anemia and hyperferritinemia.
Attallah N; Osman-Malik Y; Frinak S; Besarab A
Am J Kidney Dis; 2006 Apr; 47(4):644-54. PubMed ID: 16564942
[TBL] [Abstract][Full Text] [Related]
7. Effect of malnutrition-inflammation complex syndrome on EPO hyporesponsiveness in maintenance hemodialysis patients.
Kalantar-Zadeh K; McAllister CJ; Lehn RS; Lee GH; Nissenson AR; Kopple JD
Am J Kidney Dis; 2003 Oct; 42(4):761-73. PubMed ID: 14520627
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two recombinant erythropoietin formulations in patients with anemia due to end-stage renal disease on hemodialysis: a parallel, randomized, double blind study.
Pérez-Oliva JF; Casanova-González M; García-García I; Porrero-Martín PJ; Valenzuela-Silva CM; Hernández-Montero T; Lagarde-Ampudia M; Casanova-Kutsareva Y; Avila-Albuerne Y; Vargas-Batista A; Bobillo-López H; Herrera-Valdés R; López-Saura PA;
BMC Nephrol; 2005 May; 6():5. PubMed ID: 15910687
[TBL] [Abstract][Full Text] [Related]
9. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
[TBL] [Abstract][Full Text] [Related]
10. Excessive level of parathyroid hormone may induce the reduction of recombinant human erythropoietin effect on renal anemia.
Fujita Y; Inoue S; Horiguchi S; Kuki A
Miner Electrolyte Metab; 1995; 21(1-3):50-4. PubMed ID: 7565462
[TBL] [Abstract][Full Text] [Related]
11. Resurgence of blood transfusion therapy in erythropoietin treated hemodialysis patients.
Ifudu O; Macey LJ; Friedman EA
ASAIO J; 1995; 41(3):M426-30. PubMed ID: 8573839
[TBL] [Abstract][Full Text] [Related]
12. Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease.
Powe NR; Griffiths RI; Bass EB
J Am Soc Nephrol; 1993 Apr; 3(10):1660-71. PubMed ID: 8318682
[TBL] [Abstract][Full Text] [Related]
13. [Recombinant human erythropoietin: 18 months of continuous use in substitution hemodialysis].
Canaud B; Polito-Bouloux C; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Nephrologie; 1990; 11(1):5-10. PubMed ID: 2374643
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin: 18 months' experience in hemodialysis patients.
Canaud B; Polito-Bouloux C; Garred LJ; Rivory JP; Donnadieu P; Taib J; Florence P; Mion C
Am J Kidney Dis; 1990 Feb; 15(2):169-75. PubMed ID: 2301388
[TBL] [Abstract][Full Text] [Related]
15. Use of erythropoietin before the initiation of dialysis and its impact on mortality.
Fink J; Blahut S; Reddy M; Light P
Am J Kidney Dis; 2001 Feb; 37(2):348-55. PubMed ID: 11157377
[TBL] [Abstract][Full Text] [Related]
16. V-J combinations of T-cell receptor predict responses to erythropoietin in end-stage renal disease patients.
Wong HS; Chang CM; Kao CC; Hsu YW; Liu X; Chang WC; Wu MS; Chang WC
J Biomed Sci; 2017 Jul; 24(1):43. PubMed ID: 28697735
[TBL] [Abstract][Full Text] [Related]
17. Improvement of nutritional status in patients receiving maintenance hemodialysis after correction of renal anemia with recombinant human erythropoietin.
Tarng DC; Huang TP; Doong TI
Nephron; 1998; 78(3):253-9. PubMed ID: 9546682
[TBL] [Abstract][Full Text] [Related]
18. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
[TBL] [Abstract][Full Text] [Related]
19. [Evolution of medical practice in the care of anemia amd the use of erythropoietin in chronic renal insufficiency hemodialysis in the past six years].
Canaud B; Richard A; Fagnani F; Moreau-Defarges T; Guillon P
Nephrologie; 2002; 23(3):123-30. PubMed ID: 12087809
[TBL] [Abstract][Full Text] [Related]
20. Mortality risk in hemodialysis patients according to anemia control and erythropoietin dosing.
Santos PR; Melo AD; Lima MM; Negreiros IM; Miranda JS; Pontes LS; Rabelo GM; Viana AC; Alexandrino MT; Barros FA; Neto BR; Brito AA; Da Silva Costa A
Hemodial Int; 2011 Oct; 15(4):493-500. PubMed ID: 22111817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
